BACKGROUND: AIDS is characterised by small intestinal mucosal damage, but its aetiopathogenesis is poorly understood. Enteric infections in Africa differ from those in northern countries, where protozoan infections have been associated with severe enteropathy in AIDS patients. AIMS: To characterise enteropathy in Zambian AIDS patients compared with local controls, and to assess relative contributions of enteric infection, nutritional impairment, and immune dysfunction. METHODS: Computer aided mucosal morphometry of small intestinal biopsy specimens from 56 HIV infected Zambians with persistent diarrhoea and 26 diarrhoea free controls, followed by regression modelling. RESULTS: Patients with HIV related diarrhoea had reduced villous height and increased crypt depth compared with controls. There was no difference between HIV positive and negative controls. In regression models applied to AIDS mucosal measurements, villous height and crypt depth were related to nutritional parameters and to serum soluble tumour necrosis factor receptor p55 concentration. Crypt depth was also related to lamina propria plasma cell count. Intestinal infection was found in 79%, which consisted predominantly of microsporidia in 34%, Isospora belli in 24%, and Cryptosporidium parvum in 21%, but detection of these enteropathogens was not related to severity of enteropathy. CONCLUSIONS: Nutritional and immune disturbances were associated with enteropathy, accounting for over one third of the variation in mucosal morphometric parameters.
BACKGROUND:AIDS is characterised by small intestinal mucosal damage, but its aetiopathogenesis is poorly understood. Enteric infections in Africa differ from those in northern countries, where protozoan infections have been associated with severe enteropathy in AIDSpatients. AIMS: To characterise enteropathy in Zambian AIDSpatients compared with local controls, and to assess relative contributions of enteric infection, nutritional impairment, and immune dysfunction. METHODS: Computer aided mucosal morphometry of small intestinal biopsy specimens from 56 HIV infected Zambians with persistent diarrhoea and 26 diarrhoea free controls, followed by regression modelling. RESULTS:Patients with HIV related diarrhoea had reduced villous height and increased crypt depth compared with controls. There was no difference between HIV positive and negative controls. In regression models applied to AIDS mucosal measurements, villous height and crypt depth were related to nutritional parameters and to serum soluble tumour necrosis factor receptor p55 concentration. Crypt depth was also related to lamina propria plasma cell count. Intestinal infection was found in 79%, which consisted predominantly of microsporidia in 34%, Isospora belli in 24%, and Cryptosporidium parvum in 21%, but detection of these enteropathogens was not related to severity of enteropathy. CONCLUSIONS: Nutritional and immune disturbances were associated with enteropathy, accounting for over one third of the variation in mucosal morphometric parameters.
Entities:
Keywords:
Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Correlation Studies; Developing Countries; Diarrhea; Diseases; Eastern Africa; English Speaking Africa; Hiv Infections; Nutrition Disorders; Research Methodology; Research Report; Signs And Symptoms; Statistical Studies; Studies; Viral Diseases; Zambia
Authors: E René; C Marche; B Regnier; A G Saimot; J L Vilde; C Perrone; C Michon; M Wolf; T Chevalier; T Vallot Journal: Dig Dis Sci Date: 1989-05 Impact factor: 3.199
Authors: D Serwadda; R D Mugerwa; N K Sewankambo; A Lwegaba; J W Carswell; G B Kirya; A C Bayley; R G Downing; R S Tedder; S A Clayden; R A Weiss; A G Dalgleish Journal: Lancet Date: 1985-10-19 Impact factor: 79.321
Authors: R Colebunders; K Lusakumuni; A M Nelson; P Gigase; I Lebughe; E van Marck; B Kapita; H Francis; J J Salaun; T C Quinn Journal: Gut Date: 1988-12 Impact factor: 23.059
Authors: Marta Farràs; Kanta Chandwe; Jordi Mayneris-Perxachs; Beatrice Amadi; John Louis-Auguste; Ellen Besa; Kanekwa Zyambo; Richard Guerrant; Paul Kelly; Jonathan Richard Swann Journal: PLoS One Date: 2018-03-02 Impact factor: 3.240
Authors: Paul Kelly; Jim Todd; Sandie Sianongo; James Mwansa; Henry Sinsungwe; Max Katubulushi; Michael J Farthing; Roger A Feldman Journal: BMC Gastroenterol Date: 2009-01-22 Impact factor: 3.067
Authors: Andrea M Rehman; Susannah Woodd; George PrayGod; Molly Chisenga; Joshua Siame; John R Koethe; Douglas C Heimburger; Paul Kelly; Henrik Friis; Suzanne Filteau Journal: J Acquir Immune Defic Syndr Date: 2015-04-01 Impact factor: 3.731